Lingli Li

Lingli Li

Auto-generated profile, based on publicly available information

Lingli Li

Kidney Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland; and

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Radiology
Verified
Journal Article
Closed access
FPFeng Pan
Feng Pan
TYTianhe Ye
Tianhe Ye
PSPeng Sun
Peng Sun
SGShan Gui
Shan Gui
BLBo Liang
Bo Liang
CZChuansheng Zheng
Chuansheng Zheng
Background Chest CT is used to assess the severity of lung involvement in COVID-19 pneumonia. Purpose To determine the change in chest CT findings associated with COVID-19 pneumonia from initial di...

5 October 2021 in Radiology
Verified
Journal Article
Closed access
FPFeng Pan
Feng Pan
LYLian Yang
Lian Yang
BLBo Liang
Bo Liang
TYTianhe Ye
Tianhe Ye
LLLingli Li
Lingli Li
CZChuansheng Zheng
Chuansheng Zheng
One year after COVID-19 diagnosis, chest CT scans showed persistent abnormalities in 53 of 209 adult study participants (25%). Background The chest CT manifestations of COVID-19 from hospitalization to convalescence after 1 year are unknown. Purpose To assess chest CT manifestations of COVID-19 up to 1 year after symptom o...

15 October 2012 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Open access
LLLingli Li
Lingli Li
ELEn Yin Lai
En Yin Lai
YHYuning Huang
Yuning Huang
CEChristoph Eisner
Christoph Eisner
DMDiane Mizel
Diane Mizel
JSJurgen Schnermann
Jurgen Schnermann
Adenosine 1 receptors (A1AR) have been shown in previous experiments to play a major role in the tubuloglomerular feedback (TGF) constrictor response of afferent arterioles (AA) to increased loop of Henle flow. Overexpression studies have pointed to a critical role of vascular A1AR, but it has remained unclear whether selective deletion of A1AR from smooth muscle cells is sufficient to abolish TGF responsiveness. To address this question, we have determined TGF response magnitude in mice in which vascular A1AR deletion was achieved using the loxP recombination approach with cre recombinase being controlled by a smooth muscle actin promoter (SmCre/A1ARff). Effective vascular deletion of A1AR was affirmed by absence of vasoconstrictor responses to adenosine or cyclohexyl adenosine (CHA) in microperfused AA. Elevation of loop of Henle flow from 0 to 30 nl/min caused a 22.1 ± 3.1% reduction of stop flow pressure in control mice and of 7.2 ± 1.5% in SmCre/A1ARff mice ( P < 0.001). Maintenance of residual TGF activity despite absence of A1AR-mediated responses in AA suggests participation of extravascular A1AR in TGF. Support for this notion comes from the observation that deletion of A1ARff by nestin-driven cre causes an identical TGF response reduction (7.3 ± 2.4% in NestinCre/A1ARff vs. 20.3 ± 2.7% in controls), whereas AA responsiveness was reduced but not abolished. A1AR on AA smooth muscle cells are primarily responsible for TGF activation, but A1AR on extravascular cells, perhaps mesangial cells, appear to contribute to the TGF response.